EE-DCR中应用曲安奈德联合泪道置管的疗效分析

发布时间：2018-04-28 18:45

  本文选题：鼻内镜 + 泪囊鼻腔黏膜吻合术　； 参考：《中国现代医学杂志》2017年20期

【摘要】：目的探讨曲安奈德联合泪道置管在鼻内镜下泪囊鼻腔黏膜吻合术(EE-DCR)的治疗效果。方法选择40例(42眼)慢性泪囊炎患者行EE-DCR联合泪道置管,明胶海绵片局部覆盖泪囊鼻腔吻合瓣,表面注射40 mg/ml曲安奈德浸润术腔。1周后鼻腔清理,1个月后取出泪道置管。结果分别于术后1个月、6个月和1年行鼻内镜检查及泪道冲洗。术后1个月治疗好转率为100%,术后6个月为95.2%;术后1年为92.9%。所有患者未发生眶内损伤、鼻腔出血等术后并发症。结论 EE-DCR中应用曲安奈德联合泪道置管治疗可有效提高手术成功率,是一种有效、微创、安全的手术方法。
[Abstract]:Objective to evaluate the efficacy of triamcinolone acetonide combined with lacrimal duct placement in endoscopic dacryocystorhinostomy (EE-DCRs). Methods 40 cases (42 eyes) of chronic dacryocystitis were treated with EE-DCR combined with lacrimal duct tube. The dacryocystorhinostomy flap was partially covered by gelatin sponge film. The nasal cavity was cleaned after injection of 40 mg/ml triamcinolone acetonide for 1 week and the lacrimal duct was removed after 1 month. Results nasal endoscopy and lacrimal passage irrigation were performed 1 month, 6 months and 1 year postoperatively. The improvement rate was 100% in one month, 95.2 in 6 months after operation, and 92.9 in one year after operation. No intraorbital injury, nasal hemorrhage and other postoperative complications occurred in all patients. Conclusion Triamcinolone acetonide combined with lacrimal duct placement in EE-DCR is an effective, minimally invasive and safe method to improve the successful rate of operation.
【作者单位】： 中南大学湘雅医院;
【分类号】：R779.6
，

本文编号：1816432